111 related articles for article (PubMed ID: 10899102)
1. Hirudin reduces tissue factor expression and attenuates graft arteriosclerosis in rat cardiac allografts.
Hölschermann H; Bohle RM; Schmidt H; Zeller H; Fink L; Stahl U; Grimm H; Tillmanns H; Haberbosch W
Circulation; 2000 Jul; 102(3):357-63. PubMed ID: 10899102
[TBL] [Abstract][Full Text] [Related]
2. Hirudin reduces tissue factor expression in neointima after balloon injury in rabbit femoral and porcine coronary arteries.
Gertz SD; Fallon JT; Gallo R; Taubman MB; Banai S; Barry WL; Gimple LW; Nemerson Y; Thiruvikraman S; Naidu SS; Chesebro JH; Fuster V; Sarembock IJ; Badimon JJ
Circulation; 1998 Aug; 98(6):580-7. PubMed ID: 9714116
[TBL] [Abstract][Full Text] [Related]
3. In situ detection of tissue factor within the coronary intima in rat cardiac allograft vasculopathy.
Hölschermann H; Bohle RM; Zeller H; Schmidt H; Stahl U; Fink L; Grimm H; Tillmanns H; Haberbosch W
Am J Pathol; 1999 Jan; 154(1):211-20. PubMed ID: 9916935
[TBL] [Abstract][Full Text] [Related]
4. AP-1 and STAT-1 decoy oligodeoxynucleotides attenuate transplant vasculopathy in rat cardiac allografts.
Stadlbauer TH; Wagner AH; Hölschermann H; Fiedel S; Fingerhuth H; Tillmanns H; Bohle RM; Hecker M
Cardiovasc Res; 2008 Sep; 79(4):698-705. PubMed ID: 18511434
[TBL] [Abstract][Full Text] [Related]
5. ONO-4817, a novel matrix metalloproteinase inhibitor, attenuates allograft vasculopathy in a rat cardiac transplant.
Hariya A; Takazawa K; Yamamoto T; Amano A
J Heart Lung Transplant; 2004 Oct; 23(10):1163-9. PubMed ID: 15477110
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of endothelin-converting enzyme attenuates transplant vasculopathy and rejection in rat cardiac allografts.
Simonson MS; Herman WH; Robinson A; Schulak J; Hricik DE
Transplantation; 1999 Jun; 67(12):1542-7. PubMed ID: 10401760
[TBL] [Abstract][Full Text] [Related]
7. Upregulation and modulation of inducible nitric oxide synthase in rat cardiac allografts with chronic rejection and transplant arteriosclerosis.
Russell ME; Wallace AF; Wyner LR; Newell JB; Karnovsky MJ
Circulation; 1995 Aug; 92(3):457-64. PubMed ID: 7543380
[TBL] [Abstract][Full Text] [Related]
8. Experimental graft arteriosclerosis. I. The Lewis-to-F-344 allograft model.
Adams DH; Tilney NL; Collins JJ; Karnovsky MJ
Transplantation; 1992 May; 53(5):1115-9. PubMed ID: 1585476
[TBL] [Abstract][Full Text] [Related]
9. Diltiazem preserves direct vasodilator response but fails to suppress intimal proliferation in rat allograft coronary artery disease.
Takami H; Backer CL; Crawford SE; Pahl E; Mavroudis C
J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):67-77. PubMed ID: 8820085
[TBL] [Abstract][Full Text] [Related]
10. Influence of recombinant hirudin on tissue-factor-induced activation of coagulation in rabbits.
Kouz J; Czech J; Nicolay U; Dickneite G
Haemostasis; 1996; 26(4):179-86. PubMed ID: 8872128
[TBL] [Abstract][Full Text] [Related]
11. Prolonged cold ischemic times and less donor-recipient histocompatibility accelerate graft vascular disease.
Czer LS; Wong AV; Soukiasian H; Gallagher S; De Robertis M; Trento A
Transplant Proc; 2011 Dec; 43(10):3863-8. PubMed ID: 22172861
[TBL] [Abstract][Full Text] [Related]
12. T-cadherin expression in cardiac allograft vasculopathy: bench to bedside translational investigation.
Collot-Teixeira S; McGregor JL; Morser K; Chalabreysse L; McDermott-Roe C; Cerutti C; Guzman A; Michel JB; Boissonnat P; Sebbag L; Thivolet-Bejui F; Bricca G; Obadia JF; Roussoulières A
J Heart Lung Transplant; 2010 Jul; 29(7):792-9. PubMed ID: 20456977
[TBL] [Abstract][Full Text] [Related]
13. Low molecular weight fucan prevents transplant coronaropathy in rat cardiac allograft model.
Alkhatib B; Freguin-Bouilland C; Lallemand F; Henry JP; Litzler PY; Marie JP; Richard V; Thuillez C; Plissonnier D
Transpl Immunol; 2006 Jun; 16(1):14-9. PubMed ID: 16701171
[TBL] [Abstract][Full Text] [Related]
14. Multiglycosidorum tripterygii, a new immunosuppressant, supresses coronary arteriosclerosis after heart transplantation.
Hachida M; Zhang X; Lu H; Hoshi H; Koyanagi H
J Heart Lung Transplant; 1999 Mar; 18(3):248-54. PubMed ID: 10328151
[TBL] [Abstract][Full Text] [Related]
15. Effects of cyclosporine and 15-deoxyspergualin on coronary arteriosclerosis after heart transplantation in the rat.
Nagamine S; Ohmi M; Tabayashi K; Iguchi A; Mohri H
J Heart Lung Transplant; 1994; 13(5):895-8. PubMed ID: 7803433
[TBL] [Abstract][Full Text] [Related]
16. Experimental graft arteriosclerosis. II. Immunocytochemical analysis of lesion development.
Adams DH; Wyner LR; Karnovsky MJ
Transplantation; 1993 Oct; 56(4):794-9. PubMed ID: 8212197
[TBL] [Abstract][Full Text] [Related]
17. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.
van Loosdregt J; van Oosterhout MF; Bruggink AH; van Wichen DF; van Kuik J; de Koning E; Baan CC; de Jonge N; Gmelig-Meyling FH; de Weger RA
Circulation; 2006 Oct; 114(15):1599-607. PubMed ID: 17015796
[TBL] [Abstract][Full Text] [Related]
18. Arterial thrombin activity after angioplasty in an atherosclerotic rabbit model: time course and effect of hirudin.
Barry WL; Gimple LW; Humphries JE; Powers ER; McCoy KW; Sanders JM; Owens GK; Sarembock IJ
Circulation; 1996 Jul; 94(1):88-93. PubMed ID: 8964123
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of beraprost sodium, a stable prostacyclin analogue, on cardiac allograft vasculopathy in rats.
Kurisu Y; Orihashi K; Sueda T; Kajihara H; Matsuura Y
Hiroshima J Med Sci; 1997 Mar; 46(1):11-9. PubMed ID: 9114563
[TBL] [Abstract][Full Text] [Related]
20. Development of a combined heart and carotid artery transplant model to investigate the impact of acute rejection on cardiac allograft vasculopathy.
Soleimani B; Fu F; Lake P; Shi VC
J Heart Lung Transplant; 2008 Apr; 27(4):450-6. PubMed ID: 18374883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
